Study Reveals Link Between Forever Chemicals and Childhood Cancers
WEDNESDAY, March 5, 2025 -- There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers, according to a study published online in the February issue of Environmental Epidemiology.
Natalie R. Binczewski, from the University of California, Irvine, and colleagues investigated associations between PFAS and childhood cancers. The analysis included geocoded residences at birth linked to corresponding water district boundaries for 10,220 California-born children (aged 0 to 15 years) diagnosed with cancer (2000 to 2015) and 29,974 healthy controls.
The researchers found suggestive associations between perfluorooctanesulfonic acid and nonastrocytoma gliomas (adjusted odds ratio [aOR], 1.26; 95 percent confidence interval [CI], 0.99 to 1.60), acute myeloid leukemia (aOR, 1.14; 95 percent CI, 0.94 to 1.39), Wilms tumors (aOR, 1.15; 95 percent CI, 0.96 to 1.38), and noncentral system embryonal tumors (aOR, 1.07; 95 percent CI, 0.98 to 1.17), as well as between perfluorooctanoic acid and non-Hodgkin lymphoma (aOR, 1.19; 95 percent CI, 0.95 to 1.49). There was a significantly increased risk for Wilms tumor and noncentral system embryonal tumors among children of Mexico-born mothers.
"While these results do not confirm that PFAS exposure directly causes childhood cancers, they add to a growing body of evidence highlighting potential health risks," Binczewski said in a statement. "Further studies are needed to confirm and better understand these associations, but this research underscores the importance of clean drinking water and continued regulatory efforts to protect public health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Evidence Insufficient to Determine Benefits of Multicancer Screening Tests
THURSDAY, Sept. 18, 2025 -- No controlled studies report benefits of screening with multicancer detection (MCD) tests, according to a study published online Sept. 16 in the Annals...
Many Clinicians Not Comfortable With Hormone Therapy in Patients With History of Gynecologic Cancer
TUESDAY, Sept. 16, 2025 -- Many gynecologists and some gynecologic oncologists are uncomfortable prescribing hormone therapy to patients with a history of endometrial or...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.